Analysts Set Akamai Technologies, Inc. (NASDAQ:AKAM) Price Target at $103.26
Akamai Technologies, Inc. (NASDAQ:AKAM – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twenty-one research firms that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, nine have assigned a hold recommendation, nine have assigned a buy recommendation and two have […]
More Stories
Bristol Myers Squibb Company (NYSE:BMY) Shares Sold by Spire Wealth Management
Spire Wealth Management reduced its position in shares of Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 1.6% in...
Golden State Wealth Management LLC Acquires 974 Shares of Zoetis Inc. (NYSE:ZTS)
Golden State Wealth Management LLC increased its holdings in Zoetis Inc. (NYSE:ZTS – Free Report) by 90.6% in the first...
Zoetis Inc. (NYSE:ZTS) Shares Sold by Bessemer Group Inc.
Bessemer Group Inc. decreased its stake in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 42.6% during the 1st...
Golden State Wealth Management LLC Acquires 4,508 Shares of CSX Corporation (NASDAQ:CSX)
Golden State Wealth Management LLC increased its holdings in shares of CSX Corporation (NASDAQ:CSX – Free Report) by 123.1% in...
Golden State Wealth Management LLC Grows Stake in Meta Platforms, Inc. (NASDAQ:META)
Golden State Wealth Management LLC grew its position in Meta Platforms, Inc. (NASDAQ:META – Free Report) by 151.1% during the...
Golden State Wealth Management LLC Has $319,000 Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Golden State Wealth Management LLC increased its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 623.1% during the...